Valute / NVS
NVS: Novartis AG
114.22
USD
1.49
(1.29%)
Il tasso di cambio NVS ha avuto una variazione del -1.29% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 114.09 e ad un massimo di 115.76.
Segui le dinamiche di Novartis AG. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NVS News
- Zacks Buy These 5 Low-Leverage Stocks Amid Impressive Retail Sales Data
- Seeking Alpha Takeda: Positioned To Tackle Future Clinical Demand In A Highly Regulated Sector (TAK)
- Zacks Novartis Beats on Q2 Earnings and Sales, CFO Retires, Stock Down
- Zacks Compared to Estimates, Novartis (NVS) Q2 Earnings: A Look at Key Metrics
- Investor's Business Daily Novartis Sacrifices A Breakout As One Of Its Bread-And-Butter Drugs Misses
- Benzinga Why Is Novartis Stock Trading Lower On Thursday? - Novartis (NYSE:NVS)
- TipRanks NVS Earnings: NVS Stock Flatlines Despite Healthier Q2 Sales - TipRanks.com
- Investing Novartis ADR earnings beat by $0.07, revenue topped estimates
- Investing Novartis fails to block MSN from selling generic heart drug Entresto
- TipRanks Is NVS Stock (NVS) a Buy Ahead of Q2 Earnings? - TipRanks.com
- Zacks 3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS
- Zacks Will Key Drugs Maintain Momentum for Novartis in Q2 Earnings?
- Investing Temasek eyes more Indian family-run businesses after Haldiram’s deal
- Investor's Business Daily Stock Market Week Ahead: Blue Chips, Big Banks, GE Aerospace And Netflix Launch Q2, Congress Mulls Cryptos
- Seeking Alpha Why Novartis Stock Is Still A 'Buy' After 15% Surge (NYSE:NVS)
- TipRanks Most Anticipated Earnings this Week – Week of July 14, 2025 - TipRanks.com
- Benzinga Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study - Pfizer (NYSE:PFE)
- Seeking Alpha Stock Picks From Seeking Alpha's June 2025 New Analysts
- Benzinga Novartis Gets Swiss Approval For First Malaria Drug For Babies - Novartis (NYSE:NVS)
- Seeking Alpha Merck & Co.: A Pharma Titan At A Discount (NYSE:MRK)
- Seeking Alpha NYLI Income Builder Fund Q1 2025 Commentary
- Seeking Alpha Worried About Potential U.S. Stagflation? Consider IDVO
- Investing Switzerland seeks trade deal with Trump without getting into EU bind
- Benzinga Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial - Novartis (NYSE:NVS)
Intervallo Giornaliero
114.09
115.76
Intervallo Annuale
96.06
124.82
- Chiusura Precedente
- 114.43
- Apertura
- 115.71
- Bid
- 114.22
- Ask
- 114.52
- Minimo
- 114.09
- Massimo
- 115.76
- Volume
- 6.832 K
- Variazione giornaliera
- -1.29%
- Variazione Mensile
- -6.45%
- Variazione Semestrale
- 9.31%
- Variazione Annuale
- 2.08%
19 luglio, sabato